- Featured Product
- KD/KO Validated
CTHRC1 Polyklonaler Antikörper
CTHRC1 Polyklonal Antikörper für WB, IF/ICC, FC (Intra), IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IF/ICC, FC (Intra), IP, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 16534-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
16534-1-PBS bindet in WB, IF/ICC, FC (Intra), IP, Indirect ELISA CTHRC1 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | CTHRC1 fusion protein Ag9812 |
| Vollständiger Name | collagen triple helix repeat containing 1 |
| Berechnetes Molekulargewicht | 243 aa, 26 kDa |
| Beobachtetes Molekulargewicht | 25-30 kDa |
| GenBank-Zugangsnummer | BC014245 |
| Gene symbol | CTHRC1 |
| Gene ID (NCBI) | 115908 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Collagen triple helix repeat-containing protein 1 (CTHRC1), also known as protein NMTC1, is a glycosylated secreted protein. CTHRC1 was identified as a novel molecular in injured and diseased arteries where it may contribute to vascular remodeling by limiting collagen matrix deposition and promoting cell migration (PMID: 15618538). It has been reported that CTHRC1 is a positive regulator of osteoblastic bone formation (PMID: 18779865). Besides, studies reveal that CTHRC1 expression is implicated in various malignancies, including hepatocellular carcinoma, gastric carcinoma, colon cancer, and lung cancer (PMID: 23922981; 24504172; 24746208; 25139095).









